JW Pharmaceutical Corporation (KRX: 001060)

JW Pharmaceutical Statistics

Total Valuation

JW Pharmaceutical has a market cap or net worth of KRW 704.47 billion. The enterprise value is 746.57 billion.

Market Cap	704.47B
Enterprise Value	746.57B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

JW Pharmaceutical has 24.59 million shares outstanding. The number of shares has increased by 0.14% in one year.

Shares Outstanding	24.59M
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	0.78%
Owned by Institutions (%)	10.81%
Float	14.60M

Valuation Ratios

The trailing PE ratio is 19.05 and the forward PE ratio is 7.96. JW Pharmaceutical's PEG ratio is 0.21.

PE Ratio	19.05
Forward PE	7.96
PS Ratio	0.89
PB Ratio	2.47
P/FCF Ratio	6.60
PEG Ratio	0.21

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.50, with an EV/FCF ratio of 7.05.

EV / Earnings	21.43
EV / Sales	1.01
EV / EBITDA	6.50
EV / EBIT	7.82
EV / FCF	7.05

Financial Position

The company has a current ratio of 1.34, with a Debt / Equity ratio of 0.53.

Current Ratio	1.34
Quick Ratio	0.93
Debt / Equity	0.53
Debt / EBITDA	1.33
Debt / FCF	1.41
Interest Coverage	8.14

Financial Efficiency

Return on equity (ROE) is 13.06% and return on invested capital (ROIC) is 12.65%.

Return on Equity (ROE)	13.06%
Return on Assets (ROA)	8.88%
Return on Capital (ROIC)	12.65%
Revenue Per Employee	697.45M
Profits Per Employee	32.74M
Employee Count	1,064
Asset Turnover	1.13
Inventory Turnover	3.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.35% in the last 52 weeks. The beta is 0.51, so JW Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-22.35%
50-Day Moving Average	28,604.00
200-Day Moving Average	31,316.41
Relative Strength Index (RSI)	47.99
Average Volume (20 Days)	145,751

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, JW Pharmaceutical had revenue of KRW 742.09 billion and earned 34.83 billion in profits. Earnings per share was 1,493.10.

Revenue	742.09B
Gross Profit	330.35B
Operating Income	93.15B
Pretax Income	52.69B
Net Income	34.83B
EBITDA	112.52B
EBIT	93.15B
Earnings Per Share (EPS)	1,493.10

Balance Sheet

The company has 107.71 billion in cash and 149.82 billion in debt, giving a net cash position of -42.11 billion or -1,712.13 per share.

Cash & Cash Equivalents	107.71B
Total Debt	149.82B
Net Cash	-42.11B
Net Cash Per Share	-1,712.13
Equity (Book Value)	283.48B
Book Value Per Share	11,526.01
Working Capital	100.07B

Cash Flow

In the last 12 months, operating cash flow was 120.20 billion and capital expenditures -14.25 billion, giving a free cash flow of 105.94 billion.

Operating Cash Flow	120.20B
Capital Expenditures	-14.25B
Free Cash Flow	105.94B
FCF Per Share	4,307.56

Margins

Gross margin is 44.52%, with operating and profit margins of 12.55% and 4.80%.

Gross Margin	44.52%
Operating Margin	12.55%
Pretax Margin	7.10%
Profit Margin	4.80%
EBITDA Margin	15.16%
EBIT Margin	12.55%
FCF Margin	14.28%

Dividends & Yields

This stock pays an annual dividend of 392.16, which amounts to a dividend yield of 1.41%.

Dividend Per Share	392.16
Dividend Yield	1.41%
Dividend Growth (YoY)	12.06%
Years of Dividend Growth	8
Payout Ratio	27.11%
Buyback Yield	-0.14%
Shareholder Yield	1.27%
Earnings Yield	5.25%
FCF Yield	15.14%

Stock Splits

The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.02.

Last Split Date	Dec 27, 2023
Split Type	Forward
Split Ratio	1.02

Scores

JW Pharmaceutical has an Altman Z-Score of 3.26.

Altman Z-Score	3.26
Piotroski F-Score	n/a